Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material

Molecular and Cellular Probes

Volumn 22, Issue 2, 2008, Pages 83-89

  Haupt, Larisa M ^a   Irving, Rachel E ^a   Weinstein, Stephen R ^b   Irving, Michael G ^c   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^c BOND UNIVERSITY   (Australia)

Author keywords

Breast; Cancer; Human; IS RT PCR; Matrix metalloproteinases; Paraffin embedded

Indexed keywords

INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN;

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LOCALIZATION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE DISTRIBUTION; TUMOR BIOPSY;

BIOPSY; BREAST; BREAST NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 40149089833     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2007.06.009     Document Type: Article

References (30)

1. Weinstein S., and Wilsen J. Prognostic factors in invasive breast cancer. Todays Life Sci (1997) 16-20
2. Liotta L.A. Cancer cell invasion and metastasis. Sci Am 266 2 (1992) 54-9, 62-3
3. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9 4 (1990) 289-303
4. Freije J.M., Diez-Itza I., Balbin M., Sanchez L.M., Blasco R., Tolivia J., et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269 24 (1994) 16766-16773
5. Duffy M.J. Biochemical markers in breast cancer: which ones are clinically useful?. Clin Biochem 34 5 (2001) 347-352
6. Kamangar F., Dores G.M., and Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24 14 (2006) 2137-2150
7. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92 16 (1995) 7362-7366
8. Edvardsen K., Chen W., Rucklidge G., Walsh F.S., Obrink B., and Bock E. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc Natl Acad Sci USA 90 24 (1993) 11463-11467
9. Ries C., and Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 376 6 (1995) 345-355
10. Sato H., Kinoshita T., Takino T., Nakayama K., and Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393 1 (1996) 101-104
11. Yu M., Sato H., Seiki M., and Thompson E.W. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55 15 (1995) 3272-3277
12. Murphy G., Stanton H., Cowell S., Butler G., Knauper V., Atkinson S., et al. Mechanisms for pro matrix metalloproteinase activation. Apmis 107 1 (1999) 38-44
13. Will H., and Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231 3 (1995) 602-608
14. Brinckerhoff C.E., Rutter J.L., and Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6 12 (2000) 4823-4830
15. McDonnell S., and Matrisian L.M. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 9 4 (1990) 305-319
16. Salamonsen L.A., and Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 44 1/2 (1999) 1-27
17. Wright J.H., McDonnell S., Portella G., Bowden G.T., Balmain A., and Matrisian L.M. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 10 4 (1994) 207-215
18. Boudreau N., Myers C., and Bissell M.J. From laminin to lamin: regulation of tissue-specific gene expression by the ECM. Trends Cell Biol 5 1 (1995) 1-4
19. Saarinen J., Kalkkinen N., Welgus H.G., and Kovanen P.T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 269 27 (1994) 18134-18140
20. Heppner K.J., Matrisian L.M., Jensen R.A., and Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149 1 (1996) 273-282
21. Haupt L.M., Thompson E.W., Griffiths L.R., and Irving M.G. IS-RT-PCR assay detection of MT-MMP in a human breast cancer cell line. Biochem Mol Biol Int 39 3 (1996) 553-561
22. Haupt L.M., Thompson E.W., Trezise A.E., Irving R.E., Irving M.G., and Griffiths L.R. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts. BMC Cancer 6 (2006) 18
23. Lejour M. Evaluation of fat in breast tissue removed by vertical mammaplasty. Plast Reconstr Surg 99 2 (1997) 386-393
24. Jiang W.G., Davies G., Martin T.A., Parr C., Watkins G., Mason M.D., et al. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17 4 (2006) 583-590
25. Kim H.J., Park C.I., Park B.W., Lee H.D., and Jung W.H. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Yonsei Med J 47 3 (2006) 333-342
26. Tetu B., Brisson J., Wang C.S., Lapointe H., Beaudry G., Blanchette C., et al. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res 8 3 (2006) R28
27. Artym V.V., Zhang Y., Seillier-Moiseiwitsch F., Yamada K.M., and Mueller S.C. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66 6 (2006) 3034-3043
28. Bhuvarahamurthy V., Kristiansen G.O., Johannsen M., Loening S.A., Schnorr D., Jung K., et al. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep 15 5 (2006) 1379-1384
29. Nguyen N., Kuliopulos A., Graham R.A., and Covic L. Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res 66 5 (2006) 2658-2665
30. Poola I., DeWitty R.L., Marshalleck J.J., Bhatnagar R., Abraham J., and Leffall L.D. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med 11 5 (2005) 481-483